RSV infection and bronchiolitis: who qualifies for prevention?
(1) Approximately 80% of cases of bronchiolitis appear to be due to respiratory syncytial virus (RSV). (2) Overall, about 1% of cases of bronchiolitis lead to hospitalisation.  This rises to about 25% in children with a history of severe prematurity, bronchopulmonary dysplasia or congenital heart disease.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use; D001988:Bronchiolitis / Q000517:prevention & control / Q000821:virology; D003245:Consensus Statements as Topic; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D018357:Respiratory Syncytial Virus Infections / Q000150:complications / Q000517:prevention & control*
D000911:Antibodies, Monoclonal; D000998:Antiviral Agents